Patents-Review.com
ClassID:

170303 ⎘

G01N2333/33 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Recent Application in this class:
#1
20260115235
2026-04-30

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #2
20260092255
2026-04-02

Cell Based Assays for Botulinum

 #3
20250375488
2025-12-11

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #4
20250237648
2025-07-24

BACTERIAL BIOSENSORS FOR DIAGNOSING AND TREATING INFLAMMATION

 #5
20250179155
2025-06-05

NANOBODIES FOR TREATING C. DIFFICILE INFECTION

 #6
20250154286
2025-05-15

ANTI-PCSK9 ANTIBODIES

 #7
20250152688
2025-05-15

A Conjugate

 #8
20250129142
2025-04-24

ANTIBODIES BINDING TO TETANUS TOXIN AND USES THEREOF

 #9
20250002537
2025-01-02

Peptides for Characterization of Botulinum Neurotoxins

 #10
20240415899
2024-12-19

Bacteriotherapy for clostridium difficile colitis

 #11
20240374655
2024-11-14

INTESTINAL MICROBIOTA AND GVHD

 #12
20240329060
2024-10-03

METHOD FOR MEASURING EXTRACELLULAR VESICLES, METHOD FOR ACQUIRING INFORMATION ON NEURODEGENERATION, METHOD FOR ISOLATING EXTRACELLULAR VESICLES, AND REAGENT KIT

 #13
20240307463
2024-09-19

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #14
20240307462
2024-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

 #15
20240272160
2024-08-15

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

 #16
20240270833
2024-08-15

Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells

 #17
20240252556
2024-08-01

Bacteriotherapy for clostridium difficile colitis

 #18
20240122995
2024-04-18

Bacteriotherapy for clostridium difficile colitis

 #19
20240011985
2024-01-11

NEUTRALIZED ANTIBODY AND METHOD OF USE THEREOF

 #20
20240002443
2024-01-04

Cells for characterization of botulinum neurotoxins

 #21
20230340153
2023-10-26

Anti-PCSK9 antibodies

 #22
20230280300
2023-09-07

DEVICE, PROCEDURE AND SYSTEM FOR DETECTING BACTERIAL PATHOGENS INCLUDING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS OR CLOSTRIDIUM DIFFICILE

 #23
20230279083
2023-09-07

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #24
20230235031
2023-07-27

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #25
20230076826
2023-03-09

Bacteriotherapy for clostridium difficile colitis

 #26
20230048462
2023-02-16

METHODS FOR IDENTIFYING ANTI CLOSTRIDIAL NEUROTOXIN COMPOUNDS

 #27
20230022460
2023-01-26

Amplifier system and controls for dielectrophoretic tracking in microfluidic devices

 #28
20220390461
2022-12-08

METHOD FOR THE DETECTION OF CLOSTRIDIUM NEUROTOXINS USING A NOVEL SUBSTRATE

 #29
20220357314
2022-11-10

Cell-based Clostridal Neurotoxin Assays

 #30
20220260555
2022-08-18

Compositions and Methods for Cell-Based Assays

 #31
20220251240
2022-08-11

Antibodies for Botulinum Neurotoxins

 #32
20220244256
2022-08-04

Cell Based Assays for Botulinum Neurotoxins

 #33
20220196634
2022-06-23

Reporting construct with synaptobrevin based moiety

 #34
20220144925
2022-05-12

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #35
20220119866
2022-04-21

SNP MARKERS OF DRUG REDUCED SUSCEPTIBILITY RELATED EVOLUTIONARY BRANCHES OF CLOSTRIDIUM DIFFICILE, METHOD FOR IDENTIFYING STRAIN CATEGORY, AND USE THEREOF

 #36
20220113310
2022-04-14

CELLULAR VAMP CLEAVAGE ASSAY

 #37
20220096568
2022-03-31

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #38
20220089784
2022-03-24

Antibodies for Botulinum Neurotoxins

 #39
20210369807
2021-12-02

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

 #40
20210340229
2021-11-04

Immuno-based botulinum toxin serotype A activity assays

 #41
20210318319
2021-10-14

DETECTION OF BIOMARKERS

 #42
20210269485
2021-09-02

Vesicles for characterization of botulinum neurotoxins

 #43
20210255174
2021-08-19

Methods for detection of botulinum neurotoxin

 #44
20210236677
2021-08-05

STERILIZATION MONITOR

 #45
20210172952
2021-06-10

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

 #46
20210171614
2021-06-10

Immuno-based botulinum toxin serotype A activity assays

 #47
20210171613
2021-06-10

CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF

 #48
20210116440
2021-04-22

Means and methods for the determination of the biological activity of BoNT/E in cells

 #49
20210025889
2021-01-28

ELISA KIT FOR CLOSTRIDIUM NOVYI TYPE B

 #50
20210011002
2021-01-14

Compositions and methods for improving sensitivity in cell based assays

 #51
20210002356
2021-01-07

Human neutralizing anti-tetanus toxin monoclonal antibody and its applications

 #52
20200392212
2020-12-17

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #53
20200386746
2020-12-10

SENSOR FOR DETECTION OF BOTULINUM TOXIN USING SPUN CARBON NANOTUBE SHEET

 #54
20200363412
2020-11-19

Methods for improving uptake of neurotoxin

 #55
20200325247
2020-10-15

Antibodies for botulinum neurotoxins

 #56
20200292530
2020-09-17

Cell-based assay using electrophysiological activity measured with microelectrode arrays

 #57
20200270670
2020-08-27

CULTURE MEDIUM FOR SELECTIVELY ISOLATING BACTERIA OF GENUS CLOSTRIDIUM

 #58
20200246399
2020-08-06

Composition for inducing proliferation or accumulation of regulatory T cells

 #59
20200132690
2020-04-30

Stabilization of glutamate dehydrogenase in an aqueous solution

 #60
20200109174
2020-04-09

Reporting constructs for characterization of neurotoxins

 #61
20200093913
2020-03-26

Vaccine against necrotic enteritis in poultry

 #62
20200002769
2020-01-02

Fecal bacterial markers for colorectal cancer

 #63
20190331665
2019-10-31

Compositions and methods for improving sensitivity in cell based assays

 #64
20190324041
2019-10-24

Immuno-based retargeted endopeptidase activity assays

 #65
20190282635
2019-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

 #66
20190282634
2019-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

 #67
20190219575
2019-07-18

Cellular vamp cleavage assay

 #68
20190212336
2019-07-11

Methods, compositions and devices for improving the sensitivity of assays

 #69
20190153037
2019-05-23

Non-FRET cell based assay

 #70
20190145974
2019-05-16

Compositions and methods for improved cell-based botulinum neurotoxin assays

 #71
20190135941
2019-05-09

Anti-PCSK9 antibodies

 #72
20190106725
2019-04-11

BIOLOGICAL INDICATOR

 #73
20190046592
2019-02-14

Composition for inducing proliferation or accumulation of regulatory T cells

 #74
20190030093
2019-01-31

Composition for inducing proliferation or accumulation of regulatory T cells

 #75
20190023771
2019-01-24

Means and methods for the determination of the biological activity of BoNT/E in cells

 #76
20190017092
2019-01-17

Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same

 #77
20180363033
2018-12-20

Biomarkers for predicting infection treatment outcome

 #78
20180243351
2018-08-30

Bacteriotherapy for clostridium difficile colitis

 #79
20180238861
2018-08-23

Methods for enhancing the specific uptake of botulinum neurotoxins into cells

 #80
20180223325
2018-08-09

Methods, apparatuses and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon

 #81
20180208680
2018-07-26

Antibodies for botulinum neurotoxins

 #82
20180208643
2018-07-26

ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF

 #83
20180153981
2018-06-07

Composition for inducing proliferation or accumulation of regulatory T cells

 #84
20180134769
2018-05-17

CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF

 #85
20180074044
2018-03-15

Assay with synaptobrevin based moiety

 #86
20180072780
2018-03-15

Compositions and methods for stability testing of botulinum toxin

 #87
20180044557
2018-02-15

Apparatus for manufacturing display module

 #88
20180037614
2018-02-08

Immunoassays for differential detection of clostridium difficile

 #89
20180016616
2018-01-18

METHODS AND COMPOSITIONS FOR THE DETECTION OF FUNCTIONAL CLOSTRIDIUM DIFFICILE TOXINS

 #90
20170314013
2017-11-02

SYSTEM FOR PRODUCTION OF ANTIBODIES AND THEIR DERIVATIVES

 #91
20170266241
2017-09-21

BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS

 #92
20170258854
2017-09-14

INTESTINAL MICROBIOTA AND GVHD

 #93
20170248602
2017-08-31

Immuno-based retargeted endopeptidase activity assays

 #94
20170242006
2017-08-24

PREDICTION OF THE SUSCEPTIBILITY OF AN AT RISK PATIENT FOR DEVELOPING OR REDEVELOPING CLOSTRIDIUM DIFFICILE INFECTION

 #95
20170234865
2017-08-17

Methods, Compositions and Devices for Improving the Sensitivity of Assays

 #96
20170227429
2017-08-10

Volatile organic compounds (VOCs) for the diagnosis of -associated diarrhea (CDAD)

 #97
20170218424
2017-08-03

Amplifier system and controls for dielectrophoretic tracking in microfluidic devices

 #98
20170218021
2017-08-03

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

 #99
20170212113
2017-07-27

Predictive value of -specific immune response for recurrence and disease outcome

 #100
20170153228
2017-06-01

Substrates for detection of botulinum neurotoxin

 #101
20170097350
2017-04-06

Compositions and methods for improved cell-based botulinum neurotoxin assays

 #102
20170087197
2017-03-30

Composition for inducing proliferation or accumulation of regulatory T cells

 #103
20170059558
2017-03-02

Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems

 #104
20170029864
2017-02-02

Rapid detection of replicating cells

 #105
20170014532
2017-01-19

Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof

 #106
20170008937
2017-01-12

Compositions and methods for treating or preventing infection

 #107
20170007691
2017-01-12

Composition for inducing proliferation or accumulation of regulatory T cells

 #108
20160370361
2016-12-22

DEVICE AND METHOD FOR DETECTION OF ANALYTES

 #109
20160356776
2016-12-08

Methods and Compositions for Detecting Botulinum Neurotoxin

 #110
20160345743
2016-12-01

Buoyant pool lounge chair frame and buoyant pool lounge chair using the same

 #111
20160331800
2016-11-17

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

 #112
20160299140
2016-10-13

Stabilization of glutamate dehydrogenase in an aqueous solution

 #113
20160282337
2016-09-29

Methods, compositions and kits for assaying mitochondrial function

 #114
20160229921
2016-08-11

Antibodies for botulinum neurotoxins

 #115
20160229898
2016-08-11

Fusion proteins, cells, and kits for characterizing Botulinum toxin

 #116
20160223524
2016-08-04

Sensitized cultured cells for botulinum toxin characterization

 #117
20160202245
2016-07-14

Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells

 #118
20160151430
2016-06-02

Composition for inducing proliferation or accumulation of regulatory T cells

 #119
20160143960
2016-05-26

Composition for inducing proliferation or accumulation of regulatory T cells

 #120
20160129053
2016-05-12

METHODS OF ISOLATING MICROORGANISMS AND USES THEREOF

 #121
20160089404
2016-03-31

in the gut microbiota and association with body weight

 #122
20160069862
2016-03-10

Botulinum assay with synaptobrevin substrate moiety

 #123
20160052977
2016-02-25

Toxins in type A

#124
20160047826
2016-02-18

COMPOSITIONS AND METHODS FOR DETECTION OF A TARGET IN A MOLECULAR ASSAY USING PH CHANGES

 #125
20160017022
2016-01-21

Methods to protect against and treat multiple sclerosis

 #126
20160007758
2016-01-14

Buoyant pool lounge chair frame and buoyant pool lounge chair using the same

 #127
20160002699
2016-01-07

Method for screening food ingredients and food compositions

 #128
20150376716
2015-12-31

Method for examination of carcinogenic risk

 #129
20150362482
2015-12-17

METHODS OF DETECTING NEUROTOXIN USING SYNAPTIC ACTIVITY

 #130
20150343049
2015-12-03

Vaccine

 #131
20150329896
2015-11-19

N-end rule protease activity indication methods and uses thereof

 #132
20150320805
2015-11-12

Composition for inducing proliferation or accumulation of regulatory T cells

 #133
20150301050
2015-10-22

Immuno-based retargeted endopeptidase activity assays

 #134
20150275265
2015-10-01

Methods for diagnosing bacterial infections

 #135
20150253326
2015-09-10

Methods and Compositions for Detecting Botulinum Neurotoxin

 #136
20150198585
2015-07-16

Methods, compositions and kits for assaying mitochondrial function

 #137
20150168405
2015-06-18

OLIGONUCLEOTIDE BASED ANALYTE DETECTION METHOD

 #138
20150159194
2015-06-11

Real-time assay for the detection of botulinum toxin

 #139
20150159193
2015-06-11

Botulinum toxin assay with improved sensitivity

 #140
20150158917
2015-06-11

Toxin in type A

#141
20150143557
2015-05-21

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

 #142
20150104454
2015-04-16

Anti-C. difficile toxin antibodies and associated methods

 #143
20150030600
2015-01-29

Antibodies for botulinum neurotoxins

 #144
20150017852
2015-01-15

Buoyant pool lounge chair frame and buoyant pool lounge chair using the same

 #145
20140363894
2014-12-11

Sensors

 #146
20140349322
2014-11-27

System for determining unprocessed and partially processed neurotoxin type A

 #147
20140335543
2014-11-13

ANTIBODIES TO CLOSTRIDIUM DIFFICILE SPORES AND USES THEREOF

 #148
20140296134
2014-10-02

Methods and uses for metabolic profiling for infection

 #149
20140273039
2014-09-18

Assay for clostridium botulinum neurotoxin

 #150
20140271700
2014-09-18

Compositions and methods for treating clostridium difficile-associated diseases

 #151
20140248644
2014-09-04

Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A

 #152
20140235490
2014-08-21

Methods for detection of botulinum neurotoxin

 #153
20140234857
2014-08-21

Compositions and methods for toxigenicity testing

 #154
20140227314
2014-08-14

Engineered type IV pilin of

#155
20140219966
2014-08-07

Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with disease

 #156
20140206558
2014-07-24

System for production of antibodies and their derivatives

 #157
20140154812
2014-06-05

Real-time assay for the detection of botulinum toxin

 #158
20140141031
2014-05-22

Pathogenic bacteria

 #159
20140127675
2014-05-08

Materials and methods for detecting toxins, pathogens and other biological materials

 #160
20140120614
2014-05-01

Antibodies against clostridium difficile toxins and uses thereof

 #161
20140086877
2014-03-27

Bacteriotherapy for clostridium difficile colitis

 #162
20140038184
2014-02-06

Methods of diagnosing infection

 #163
20140024063
2014-01-23

Methods and compounds for increasing sensitivity of botulinum assays

 #164
20140004541
2014-01-02

Method for the determination of botulinum neurotoxin biological activity

 #165
20130273642
2013-10-17

Device and method for detection of analytes

 #166
20130230537
2013-09-05

-specific antibodies and uses thereof

 #167
20130164774
2013-06-27

METHODS, COMPOSITIONS AND KITS FOR ASSAYING MITOCHONDRIAL FUNCTION

 #168
20130065259
2013-03-14

Methods for detection of botulinum neurotoxin

 #169
20130052640
2013-02-28

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease

 #170
20130045274
2013-02-21

Bacteriotherapy for clostridium difficile colitis

 #171
20130040368
2013-02-14

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

 #172
20130034847
2013-02-07

OLIGONUCLEOTIDE BASED ANALYTE DETECTION METHOD

 #173
20130022992
2013-01-24

In vitro assay for quantifying clostridial neurotoxin activity

 #174
20120322081
2012-12-20

METHODS FOR DETECTION OF BOTULINUM NEUROTOXIN

 #175
20120309039
2012-12-06

Non-FRET botulinum assay

 #176
20120301912
2012-11-29

METHODS, COMPOSITIONS AND KITS FOR ASSAYING MITOCHONDRIAL FUNCTION

 #177
20120288508
2012-11-15

Antibodies against clostridium difficile toxins and uses thereof

 #178
20120282647
2012-11-08

ASSAY FOR QUANTIFYING CLOSTRIDIAL NEUROTOXIN

 #179
20120276060
2012-11-01

FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE

 #180
20120276059
2012-11-01

FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE

 #181
20120225436
2012-09-06

Immuno-based botulinum toxin serotype A activity assays

 #182
20120220490
2012-08-30

Method and compositions for detecting botulinum neurotoxin

 #183
20120214182
2012-08-23

System for determining unprocessed and partially processed neurotoxin type A

 #184
20120164657
2012-06-28

Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin action

 #185
20120122128
2012-05-17

Immuno-based botulinum toxin serotype A activity assays

 #186
20120122127
2012-05-17

Cleavage sensitive antibodies and methods of use thereof

 #187
20120070382
2012-03-22

Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof

 #188
20120064105
2012-03-15

Engineered type IV pilin of

#189
20110318385
2011-12-29

Engineered botulinum neurotoxin C1 with selective substrate specificity

 #190
20110318240
2011-12-29

Device and method for detection of analytes

 #191
20110269148
2011-11-03

Nanoaggregate Embedded Beads Conjugated To Single Domain Antibodies

 #192
20110217728
2011-09-08

HIGH THROUGHPUT TEST METHOD FOR EVALUATION OF BIOCIDES AGAINST ANAEROBIC MICROORGANISMS

 #193
20110206616
2011-08-25

Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery

 #194
20110183360
2011-07-28

Antibodies to spores and uses thereof

 #195
20110117669
2011-05-19

MATERIALS AND METHODS FOR DETECTING TOXINS, PATHOGENS AND OTHER BIOLOGICAL MATERIALS

 #196
20110105940
2011-05-05

METHOD FOR QUANTIFICATION OF TITER OF NEUTRALIZING ANTIBODY TO NEUROTOXIN

 #197
20110065902
2011-03-17

High affinity human antibodies to PCSK9

 #198
20110065123
2011-03-17

Methods for diagnosis of and methods and vectors for recombinant toxin expression

 #199
20100284958
2010-11-11

BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy

 #200
20100278856
2010-11-04

Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy

 #201
20100248281
2010-09-30

Rapid detection of replicating cells

 #202
20100233741
2010-09-16

Immuno-based retargeted endopeptidase activity assays

 #203
20100233182
2010-09-16

Antibodies against toxins and uses thereof

 #204
20100233181
2010-09-16

Antibodies against clostridium difficile toxins and uses thereof

 #205
20100209955
2010-08-19

Methods for the delivery of toxins or enzymatically active portions thereof

 #206
20100203559
2010-08-12

Immuno-based botulinum toxin serotype A activity assays

 #207
20100166768
2010-07-01

High affinity human antibodies to PCSK9

 #208
20100151494
2010-06-17

FRET protease assays for clostridial toxins

 #209
20100112082
2010-05-06

Determining and reducing immunoresistance to a toxin therapy using toxin B peptides

 #210
20100111962
2010-05-06

Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides

 #211
20100081158
2010-04-01

FRET protease assays for clostridial toxins

 #212
20100081157
2010-04-01

FRET protease assays for clostridial toxins

 #213
20100081156
2010-04-01

FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY

 #214
20100081155
2010-04-01

FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY

 #215
20100075358
2010-03-25

Fret protease assays for clostridial toxins

 #216
20100075357
2010-03-25

FRET protease assays for clostridial toxins

 #217
20100075346
2010-03-25

FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS

 #218
20090315987
2009-12-24

Rapid detection of replicating cells

 #219
20090305263
2009-12-10

Probe, probe set, probe-immobilized carrier, and genetic testing method

 #220
20090191583
2009-07-30

Clostridial toxin activity assays

 #221
20090176259
2009-07-09

Methods for detection of botulinum neurotoxin

 #222
20090130087
2009-05-21

METHOD FOR MEASURING THE CONTENT OF A BOTULINUM TOXIN IN A FORMULATION

 #223
20090117587
2009-05-07

High-affinity monoclonal antibodies for botulinum toxin type A

 #224
20090042231
2009-02-12

FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS

 #225
20090004680
2009-01-01

Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin A peptides

 #226
20080305510
2008-12-11

Fluorescence polarization assays for determining clostridial toxin activity

 #227
20080305509
2008-12-11

Fluorescence polarization assays for determining clostridial toxin activity

 #228
20080293085
2008-11-27

Fluorescence polarization assays for determining clostridial toxin activity

 #229
20080293084
2008-11-27

Fluorescence polarization assays for determining clostridial toxin activity

 #230
20080274480
2008-11-06

Botulinum Toxin Type a Immunoresistant Assay

 #231
20080247952
2008-10-09

Method for quantifying a cholinergic neurotoxin in a sample

 #232
20080226627
2008-09-18

Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II

 #233
20080220456
2008-09-11

Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity

 #234
20080213796
2008-09-04

GFP-SNAP25 fluorescence release assay for botulinum toxin protease activity

 #235
20080213255
2008-09-04

Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides

 #236
20080176249
2008-07-24

GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity

 #237
20080171348
2008-07-17

GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity

 #238
20080171347
2008-07-17

DETERMINING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY USING BOTULINUM TOXIN A PEPTIDES

 #239
20080166739
2008-07-10

GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity

 #240
20080096189
2008-04-24

Device and method for detection of analytes

 #241
20080064054
2008-03-13

FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY

 #242
20080038756
2008-02-14

FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS

 #243
20080032318
2008-02-07

FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS

 #244
20070259391
2007-11-08

Assessment of the effects of topical administration of chemodenervating pharmaceuticals

 #245
20070243565
2007-10-18

Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity

 #246
20070237792
2007-10-11

Method for measuring the content of a toxin in a formulation

 #247
20070231336
2007-10-04

Immunization Against Clostridium Difficile Disease

 #248
20070218516
2007-09-20

Recombinant chimeric human anti-botulinum antibodies

 #249
20070218084
2007-09-20

Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy

 #250
20070218005
2007-09-20

NUCLEI DENSITY AND NUCLEI AREA METHODS FOR DETERMINING THE EFFECTS OF A BOTULINUM TOXIN ON MUSCLES

 #251
20070218001
2007-09-20

Biotherapeutics, Diagnostics and Research Reagents

 #252
20070179281
2007-08-02

BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy

 #253
20070178085
2007-08-02

BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy

 #254
20070172497
2007-07-26

BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy

 #255
20070092449
2007-04-26

Methods for direct visualization of active synapses

 #256
20070071763
2007-03-29

Clostridium difficile focussed antibodies

 #257
20060257891
2006-11-16

Method for effecting the rapid release of a signature chemical from bacterial endospores, and for detection thereof

 #258
20060177881
2006-08-10

Antibodies against type A botulinum neurotoxin

 #259
20060154314
2006-07-13

GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity

 #260
20060134722
2006-06-22

Method and compositions for detecting botulinum neurotoxin

 #261
20060063222
2006-03-23

Fluorescence polarization assays for determining clostridial toxin activity

 #262
20060063221
2006-03-23

Lanthanide-based substrates and methods for determining clostridial toxin activity

 #263
20060029608
2006-02-09

Immunization against clostridium difficile disease

 #264
20050287622
2005-12-29

High throughput assays for the proteolytic activities of clostridial neurotoxins

 #265
20050287150
2005-12-29

Antibodies against toxins and uses thereof

 #266
20050158796
2005-07-21

Use of a tag to enrich polypeptides libraries

 #267
20050106700
2005-05-19

Method of purifying recombinant fused protein and method of producing protein using the same

 #268
20050100973
2005-05-12

GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity

 #269
20050019338
2005-01-27

Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles

 #270
10236105
2018-06-19

Rapid and sensitive detection of molecules